You just read:

Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients

News provided by

Neuralstem, Inc.

Sep 24, 2019, 07:30 ET